who runs the console / editorial
About Dr BPC-157
An independent editorial project that reads the published BPC-157 literature as a research console — and is explicit about what it is and is not.
What this site is
Dr BPC-157 is an independent editorial project that publishes summaries of the peer-reviewed research literature on BPC-157. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site treats the literature as a console: the genuinely established preclinical findings — the transected-Achilles tendon recovery [1], the VEGFR2-Akt-eNOS angiogenesis mechanism [3], the 2022 pharmacokinetic characterization [2] — are logged with a clear signal, and the honest gaps are flagged just as plainly. The evidence is overwhelmingly preclinical, only three small human pilots exist, and no validated human pharmacokinetics have been established [8]. We surface that asymmetry rather than smoothing it over, because the most truthful single thing to say about BPC-157 is that the evidence is real but thin and largely confined to animals.
That editorial stance shapes what gets emphasized. A finding replicated across many rodent models is reported as such; a claim resting on a single uncontrolled pilot is labeled as preliminary; a popular claim with no published support — weight loss, muscle building in healthy subjects — is named as unsupported rather than quietly omitted. The goal is a reader who leaves knowing both what the studies measured and where they stop.
About the name
The "Dr" in Dr BPC-157 is editorial framing, not a claim about services. It signals the instrument-panel register of a research console — a place where the record is read carefully and logged to source — not a doctor, a clinic, or a consultation service. We do not offer treatment, consultation, prescriptions, or any healthcare service, and nothing on this site should be read as an individualized medical or legal opinion.
We have no physical clinic, no medical staff, and no products. We are a reading of the published research and the FDA-citable regulatory record, written for general readers who want the studies summarized accurately and the open questions named.
How we cite
Every quantitative claim on this site — every dose, percentage, half-life, and biomarker result — maps to a numbered study in the full reference list with DOIs and PMIDs. Preclinical findings are indexed to PubMed; regulatory facts are cited to FDA.gov pages. Where a claim cannot be sourced to a published study or an authoritative regulatory page, we do not make it.
The site does not sell BPC-157, does not link to vendors, and does not provide acquisition guidance. It is a digest of the science and the regulatory landscape — a console for reading the record, kept honest about both what the studies show and where they stop.